Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK's Nuffield bolsters imaging services with wireless-device IT overhaul:

This article was originally published in Clinica

Executive Summary

UK not-for-profit group Nuffield Hospitals is installing an integrated IT network that will radically transform its picture archiving and communications system (PACS) activities, featuring bedside access to patient scans in combination with medical records. So claims Scalable Networks (Bourne End, Buckinghamshire) of its £2m ($4m) seven-year installation and management agreement. Over the next two months, 40 Nuffield sites will be interconnected by a system said to be capable of handling more than 10,000 users and devices, including wireless-connected medical equipment. For Nuffield, the "more efficient imaging processes" promised by the system are central to its role as partner to the NHS, ahead of next year's 18-week referral-to-treatment targets.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049329

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel